COPD Therapeutics Market Share

  • Report ID: 4210
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

COPD Therapeutics Market Share

Regionally, the global COPD therapeutics market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America is projected to hold the largest market share by the end of 2031. Well-developed health care industry, comprehensive research & development, strong reimbursement policies as well as a large number of market key players in the region encouraging advanced and efficient products are factors expected to drive the COPD therapeutics market in the region during the forecast period. Furthermore, the increasing incidence of chronic obstructive pulmonary disease and asthma in the region along with the growing patient population is anticipated to drive the regional market over the forecast period. For instance, in 2020, there were 25,257,138 people suffering from asthma in the region. In addition, in 2018, chronic lower respiratory disease (COPD) ranked as the fourth leading cause of death in the United States. There were almost 15.7 million Americans (6.4%) who have been affected by COPD in 2018.

Research Nester
COPD Therapeutics Market Overview Chart
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4210
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of COPD therapeutics is assessed at USD 12.78 billion.

COPD Therapeutics Market size was valued at USD 12.27 billion in 2023 and is anticipated to reach USD 23.72 billion by 2036, expanding at around 5.2% CAGR during the forecast period i.e., between 2024-2036. Rising prevalence of COPD and asthma along with higher consumption of tobacco smoking will impel the market growth.

North America industry is set to account for largest revenue share by 2036, led by well-developed health care industry, comprehensive research & development, strong reimbursement policies as well as a large number of market key players in the region encouraging advanced and efficient products.

The major players in the market are Almirall, S.A, AstraZeneca PLC, Boehringer Ingelheim International GmbH, CHIESI Farmaceutici S.p.A., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Kyowa Kirin Co., Ltd., Mylan N.V., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample